Company / Working Capital per Share
Neogen Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$1.86
FY2025
5-year range
$1.86 / $5.11
FY2021-FY2025
Trend
-7.7%
vs FY2024
Sector context
#123 of 163
Health Care
What the data says
Neogen's working capital per share of $1.86 is lower than 75% of companies in the Health Care sector (FY2025). Working Capital per Share has declined for 3 consecutive years, from $5.11 in FY2022 to $1.86 in FY2025.
Based on SEC 10-K filings.
1.86 in FY2025 with a 5-year CAGR of -27.6%.
Declined from $4.09 to $1.86 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -28.6%
- 5-Year CAGR
- -27.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 163This company $1.86 Sector average $24.09
▼
-92.3% below sector average
Key checks
Key Insights
- Neogen's working capital per share has declined for 3 consecutive years.
- In FY2025, working capital per share decreased 7.7% year-over-year.
- Ranks #123 out of 163 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.86 | -7.7% |
| FY2024 | $2.01 | -50.8% |
| FY2023 | $4.09 | -20.0% |
| FY2022 | $5.11 | +0.6% |
| FY2021 | $5.08 | -45.8% |
| FY2020 | $9.36 | +17.8% |
| FY2019 | $7.95 | +20.1% |
| FY2018 | $6.62 | -3.2% |
| FY2017 | $6.84 | +15.6% |
| FY2016 | $5.92 | +5.6% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026